Insider NameBuy/SellCompany NameTickerAmountShares Change
May 14, 2024May 15, 2024Chevallard Daniel R.
CFO
BuyLenz Therapeutics, Inc.LENZ$15.68$49,988+50.00%
Feb 27, 2024Feb 28, 2024Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$0.73$2,493-3.22%
Nov 28, 2023Nov 29, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$0.5$1,860-3.63%
Aug 28, 2023Aug 29, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.45$5,092-3.54%
May 25, 2023May 26, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.42$5,160-3.79%
Feb 27, 2023Feb 28, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.68$6,051-3.89%
Nov 28, 2022Nov 29, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$2.72$9,606-3.96%
Aug 26, 2022Aug 30, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$4.02$14,679-4.25%
May 26, 2022May 27, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.9$6,836-4.35%
Feb 28, 2022Mar 02, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$2.78$11,112-5.01%
Nov 26, 2021Nov 30, 2021Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$4.81$36,464-9.41%
Jul 01, 2019Jul 02, 2019Chevallard Daniel R.
CFO
SellRegulus Therapeutics Inc.RGLS$1.31$3,500-3.31%
May 15, 2019May 16, 2019Chevallard Daniel R.
CFO
SellRegulus Therapeutics Inc.RGLS$1.41$14,089-11.04%
Apr 01, 2019Apr 03, 2019Chevallard Daniel R.
CFO
SellRegulus Therapeutics Inc.RGLS$0.98$3,192-25.77%
Jul 25, 2017Jul 25, 2017Chevallard Daniel R.
CFO
BuyRegulus Therapeutics Inc.RGLS$0.91$50,000+48.05%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.